FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
0.8087
-0.0638 (-7.31%)
At close: Jun 13, 2025, 4:00 PM
0.7901
-0.0186 (-2.30%)
After-hours: Jun 13, 2025, 5:08 PM EDT
FibroBiologics Market Cap
FibroBiologics has a market cap or net worth of $30.94 million as of June 13, 2025. Its market cap has decreased by -92.70% in one year.
Market Cap
30.94M
Enterprise Value
29.06M
1-Year Change
-92.70%
Ranking
Category
Stock Price
$0.81
Market Cap Chart
Since January 31, 2024, FibroBiologics's market cap has decreased from $945.52M to $30.94M, a decrease of -96.73%. That is a compound annual growth rate of -91.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 13, 2025 | 30.94M | -55.90% |
| Dec 31, 2024 | 70.17M | -92.58% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 725.92B |
| Johnson & Johnson | 373.57B |
| Novo Nordisk | 353.21B |
| AbbVie | 338.27B |
| UnitedHealth Group | 281.72B |
| Abbott Laboratories | 235.37B |
| Novartis AG | 231.84B |
| AstraZeneca | 229.07B |